AI-generated summary
The authors evaluated a blue-diode laser photobiomodulation protocol in 12 women with vulvar lichen sclerosus, with sessions three times weekly for two weeks and follow-up over 16 weeks. They report reductions in itching and pain and improvements in erythema and fissures, with no side effects observed. The authors describe the findings as suggesting a possible therapeutic option, and the abstract notes the sample was small.
- Participants
- 12
- Who or what was studied
- 12 female patients with vulvar lichen sclerosus
- Limits stated in the abstract
- The abstract describes a small cohort of 12 patients and does not mention a control group.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on pagepress.org.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Photobiomodulation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.